PTC Therapeutics Inc (NAS:PTCT)
$ 35.81 -1.09 (-2.95%) Market Cap: 2.75 Bil Enterprise Value: 2.28 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 70/100

Q2 2020 PTC Therapeutics Inc Earnings Call Transcript

Aug 05, 2020 / 08:30PM GMT
Release Date Price: $48.97 (+0.99%)
Operator

Ladies and gentlemen, thank you for standing by. And welcome to the PTC Therapeutics Second Quarter 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions) I will now turn the conference to your host, Mr. Alex Kane, Head of Investor Relations at PTC. Sir, please go ahead.

Alex Kane
PTC Therapeutics, Inc. - IR Officer

Thank you. Good afternoon. And thank you for joining us to discuss the PTC Therapeutics' Second Quarter 2020 Corporate Update and Financial Results. Joining me on today's call is our Chief Executive Officer, Stuart Peltz; our Chief Financial Officer, Emily Hill; our Chief Development Officer, Matthew Klein; and our Chief Business Officer, Eric Pauwels.

Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Please take a moment to review the slide posted on our Investor Relations website in conjunction with the call, which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot